This brand name is authorized in Nigeria.
The drug METRONE contains one active pharmaceutical ingredient (API):
1
|
UNII
140QMO216E - METRONIDAZOLE
|
|
Metronidazole is an anti-infectious drug belonging to the pharmacotherapeutic group of nitroimidazole derivatives, which have effect mainly on strict anaerobes. This effect is probably caused by interaction with DNS and different metabolites. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| 04-8438 | Suspension | METRONE SUSPENSION SUSP 200 mg/5 mL 60ML | 10 RNW-PP-319064 METRONE SUSPENSION METRONIDAZOLE 200MG/ 5ML METRONIDAZOLE 200MG/5ML Apr-38 Drugs Nigerian Products 60ML POM 1 2/28/2023 FIDSON HEALTHCARE PLC, IKORODU ROAD, OBANIKORO LAGOS LAGOS 8023067964 nmakaokolo@yahoo.com Fidson Healthcare Plc., KM 38, Lagos- Abeokuta Expressway Sango-ota, Ogun State., Nigeria | 31/01/2024 |
| 04-9620 | Tablet | METRONE 200MG TABLET TAB 200 mg 10X10,1X1000 | 7 RNW-PP-313654 METRONE 200MG TABLET METRONIDAZOLE 200MG Metronidazole 200MG Apr-20 Drugs Nigerian Products 10X10,1X1000 POM 1 2/8/2023 FIDSON HEALTHCARE PLC, IKORODU ROAD, OBANIKORO LAGOS LAGOS 8023067964 nmakaokolo@yahoo.com Fidson Healthcare Plc., KM 38, Lagos- Abeokuta Expressway Sango-ota, Ogun State., Nigeria | 31/01/2024 |
| A11-0242 | Intravenous infusion | METRONE INTRAVENOUS INFUSION METRONIDAZOLE 500MG INJ_SOL 500 mg 100ML | 8 RNW-PP-313679 METRONE INTRAVENOUS INFUSION METRONIDAZOLE 500MG METRONIDAZOLE 500MG A11-0242 Drugs Nigerian Products 100ML POM 1 2/9/2023 FIDSON HEALTHCARE PLC, IKORODU ROAD, OBANIKORO LAGOS LAGOS 8023067964 nmakaokolo@yahoo.com Fidson Healthcare Plc., KM 38, Lagos- Abeokuta Expressway Sango-ota, Ogun State., Nigeria | 31/01/2024 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| J01XD01 | Metronidazole | J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01X Other antibacterials → J01XD Imidazole derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | 04-8438, 04-9620, A11-0242 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.